Ignota Labs
PrivateLast Round
Seed
Feb 26, 2025
Total Funding Raised
$6.9M
Momentum Score
25 /100
Company Overview
Ignota Labs is a biotechnology company that utilizes its proprietary AI platform, SAFEPATH, to identify and mitigate toxicity issues in promising drugs that were abandoned during clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ignota Labs Comps
Public and private peers based on sector, stage, and business model.
Ignota Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 26, 2025 |
Key People
Founding team and executive leadership
Ignota Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Montage Ventures | Seed |
| Gaingels | Seed |
| Blue Wire Capital | Seed |
| Modi Ventures | Seed |
| AIX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2025
$7M raised in Seed round.
Ignota Labs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ignota Labs's valuation, stock price, and market status.
